Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Dec 1;7(12):9090-8.
eCollection 2014.

Immunohistochemical expression of matrix metalloproteinase-9 and inhibitor of matrix metalloproteinase-1 in prostate adenocarcinoma

Affiliations
Comparative Study

Immunohistochemical expression of matrix metalloproteinase-9 and inhibitor of matrix metalloproteinase-1 in prostate adenocarcinoma

Igor I Babichenko et al. Int J Clin Exp Pathol. .

Abstract

An immunohistochemical study on the cells proliferative activity by Ki-67 protein and localization of the matrix metalloproteinase-9 and the inhibitor of matrix metalloproteinase-1 was carried out at the benign prostatic hyperplasia (BPH) and the adenocarcinoma (AC) of different Gleason's grades. A significant decrease of the MMP-9 and TIMP-1 level in the AC of different gradations was observed. A moderate positive correlation between the Gleason score and cell proliferation Ki-67 index (rs = 0.674) and a moderate negative correlation with the level of such a score and expression of MMP-9 (rs = -0.660) was detected. A weak negative correlation exists also between the level of proliferative activity of secretory cells and the expression of MMP-9 by tumor cells (rs = -0.369). The invasive properties of AC cells that promote a degradation of the basal membrane and connective tissue in prostate may be explained by the imbalance between the MMP-9 and TIMP-1, which expression is significantly reduced in AC, in comparison with BPH.

Keywords: Adenocarcinoma of the prostate; Ki-67; MMP-9; TIMP-1; collagen IV.

PubMed Disclaimer

Figures

Figure 1
Figure 1
IHC reaction in benign hyperplasia (A, B) and prostate adenocarcinoma with the Gleason’s grade 2 (C, D) and 4 (E, F) with antibodies to Ki-67 (A, C, E) and collagen type IV (B, D, F). Staining: DAB-Mayer hematoxylin (Magnification ×400).
Figure 2
Figure 2
IHC reaction in benign hyperplasia (A, B) and prostate adenocarcinoma with the Gleason’s grade 2 (C, D) and 4 (E, F) with antibody to MMP-9 (A, C, E) and TIMP-1 (B, D, F). Staining: DAB-Mayer hematoxylin (Magnification ×400).

Similar articles

Cited by

References

    1. Humphrey PA. Diagnosis of adenocarcinoma in prostate needle biopsy tissue. J Clin Pathol. 2007;60:35–42. - PMC - PubMed
    1. Castellano G, Malaponte G, Mazzarino MC, Figini M, Marchese F, Gangemi P, Travali S, Stivala F, Canevari S, Libra M. Activation of the osteopontine/matrix metalloproteinase-9 pathway correlates with prostate cancer progression. Clin Cancer Res. 2008;14:7470–80. - PubMed
    1. Vargas R, Jacobus S, Leitzel K, Regan MM, Hamer P, Pierce K, Brown-Shimer S, Carney W, Ali SM, Kantoff PW, Lipton A. Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients. Cancer. 2011;117:517–25. - PubMed
    1. Roy R, Louis G, Loughlin KR, Wiederschain D, Kilroy SM, Lamb CC, Zurakowski D, Moses MA. Tumor-specific urinary MMP fingerprinting: identification of high molecular weight urinary MMP species. Clin Cancer Res. 2008;14:6610–17. - PMC - PubMed
    1. Fan HX, Li HX, Chen D, Gao ZX, Zheng JH. Changes in the expression of MMP2, MMP9, and Col IV in stromal cells in oral squamous tongue cell carcinoma: relationships and prognostic implications. J Exp Clin Cancer Res. 2012;31:90. - PMC - PubMed

Publication types

MeSH terms